Enovis Corporation (ENOV)

$48.06

-1.21 (-2.46%)
Rating:
Recommendation:
-
Symbol ENOV
Price $48.06
Beta 2.231
Volume Avg. 0.38M
Market Cap 2.601B
Shares () -
52 Week Range 46.795-94.09639
1y Target Est -
DCF Unlevered ENOV DCF ->
DCF Levered ENOV LDCF ->
ROE 4.55% Neutral
ROA 2.04% Neutral
Operating Margin -
Debt / Equity 29.01% Neutral
P/E 10.18 Strong Buy
P/B 0.74 Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest ENOV news


Industrials
Specialty Industrial Machinery
New York Stock Exchange

Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.